LeMaitre Vascular (LMAT) News Today $86.07 +2.58 (+3.09%) Closing price 03/24/2025 04:00 PM EasternExtended Trading$86.06 -0.01 (-0.01%) As of 03/24/2025 05:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Summit Creek Advisors LLC Reduces Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Summit Creek Advisors LLC lowered its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 13.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 175,859 shares of the meMarch 25 at 5:45 AM | marketbeat.comBridge City Capital LLC Boosts Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Bridge City Capital LLC increased its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 7.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 94,471 shares of the medical instruments supplier's stock after purchMarch 24 at 6:59 AM | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Purchased by Teacher Retirement System of TexasTeacher Retirement System of Texas increased its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 31.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 101,851 shares of the medical instrumentsMarch 23 at 4:34 AM | marketbeat.comPrecision Optics Appoints Joseph P. Pellegrino, Jr. to Board of DirectorsMarch 20, 2025 | globenewswire.comCharles Schwab Investment Management Inc. Acquires 4,241 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)Charles Schwab Investment Management Inc. boosted its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 2.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 195,752 shares ofMarch 20, 2025 | marketbeat.com161,708 Shares in LeMaitre Vascular, Inc. (NASDAQ:LMAT) Purchased by Raymond James Financial Inc.Raymond James Financial Inc. acquired a new position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm acquired 161,708 shares of the medical instruments supplier's stock, valued at approximately $14,900,March 19, 2025 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Insider Sells $164,979.08 in StockLeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) insider Trent G. Kamke sold 2,009 shares of the firm's stock in a transaction on Wednesday, March 12th. The stock was sold at an average price of $82.12, for a total transaction of $164,979.08. Following the completion of the sale, the insider now directly owns 5,564 shares in the company, valued at approximately $456,915.68. This trade represents a 26.53 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.March 15, 2025 | marketbeat.comTrent G. Kamke Sells 2,009 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) StockMarch 15, 2025 | insidertrades.comBank of New York Mellon Corp Lowers Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Bank of New York Mellon Corp lowered its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 3.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 178,747 shares of the medical instMarch 12, 2025 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Will Pay A Larger Dividend Than Last Year At $0.20March 12, 2025 | uk.finance.yahoo.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Looks Like A Good Stock, And It's Going Ex-Dividend SoonMarch 8, 2025 | uk.finance.yahoo.comRSI Alert: LeMaitre Vascular (LMAT) Now OversoldMarch 8, 2025 | nasdaq.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Recommendation of "Moderate Buy" by AnalystsShares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) have received an average rating of "Moderate Buy" from the nine research firms that are presently covering the company, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation, four have given aMarch 8, 2025 | marketbeat.comGeneva Capital Management LLC Sells 12,263 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)Geneva Capital Management LLC trimmed its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 1.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 865,582 shares of the medical instrumentsMarch 7, 2025 | marketbeat.comBahl & Gaynor Inc. Sells 7,081 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)Bahl & Gaynor Inc. reduced its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 5.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 122,247 shares of the medical instruments supplier's stMarch 5, 2025 | marketbeat.comLeMaitre to Participate at Upcoming Investor Conferences in MarchMarch 3, 2025 | globenewswire.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Declares Dividend Increase - $0.20 Per ShareLeMaitre Vascular, Inc. (NASDAQ:LMAT) announced a quarterly dividend on Monday, March 3rd. Stockholders of record on Thursday, March 13th will be given a dividend of 0.20 per share by the medical instruments supplier on Thursday, March 27th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.87%. The ex-dividend date is Thursday, March 13th. This is a positive change from LeMaitre Vascular's previous quarterly dividend of $0.16.March 3, 2025 | marketbeat.comQ3 Earnings Estimate for LMAT Issued By Barrington ResearchLeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) - Stock analysts at Barrington Research lifted their Q3 2025 earnings estimates for LeMaitre Vascular in a report issued on Friday, February 28th. Barrington Research analyst M. Petusky now anticipates that the medical instruments supplier willMarch 3, 2025 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Shares Gap Down - Time to Sell?LeMaitre Vascular (NASDAQ:LMAT) Shares Gap Down - Should You Sell?March 1, 2025 | marketbeat.comLake Street Capital Issues Positive Forecast for LeMaitre Vascular (NASDAQ:LMAT) Stock PriceLake Street Capital increased their price objective on LeMaitre Vascular from $105.00 to $110.00 and gave the stock a "buy" rating in a research note on Friday.March 1, 2025 | marketbeat.comOppenheimer Downgrades LeMaitre Vascular (NASDAQ:LMAT) to Market PerformOppenheimer downgraded LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a research report on Friday.March 1, 2025 | marketbeat.comBarrington Research Downgrades LeMaitre Vascular (LMAT)March 1, 2025 | msn.comLeMaitre Vascular (NASDAQ:LMAT) Downgraded by Barrington Research to "Market Perform"Barrington Research cut shares of LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a research note on Friday.March 1, 2025 | marketbeat.comIllumine Investment Management LLC Invests $1.24 Million in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Illumine Investment Management LLC purchased a new position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 13,432 shares of the medical instruments supplier's stock, valuedMarch 1, 2025 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock Position Lifted by Principal Financial Group Inc.Principal Financial Group Inc. grew its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 3.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 108,617 shares of the medical insMarch 1, 2025 | marketbeat.comLeMaitre Vascular, Inc.: LeMaitre Q4 2024 Financial ResultsFebruary 28, 2025 | finanznachrichten.deStifel Nicolaus Keeps Their Buy Rating on Lemaitre Vascular (LMAT)February 28, 2025 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: 89bio (ETNB), Lemaitre Vascular (LMAT)February 28, 2025 | markets.businessinsider.comLeMaitre Vascular (NASDAQ:LMAT) Issues Earnings ResultsLeMaitre Vascular (NASDAQ:LMAT - Get Free Report) issued its earnings results on Thursday. The medical instruments supplier reported $0.49 earnings per share for the quarter, hitting analysts' consensus estimates of $0.49. LeMaitre Vascular had a return on equity of 13.15% and a net margin of 19.40%.February 28, 2025 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Issues Q1 2025 Earnings GuidanceLeMaitre Vascular (NASDAQ:LMAT) updated its first quarter 2025 earnings guidance. The company provided EPS guidance of 0.480-0.530 for the period, compared to the consensus estimate of 0.510. The company also issued revenue guidance of $56.7 millionillion-$58.7 millionillion, compared to the consensus estimate of $58.1 millionillion.February 28, 2025 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Updates FY 2025 Earnings GuidanceLeMaitre Vascular (NASDAQ:LMAT) updated its FY 2025 earnings guidance. The company provided EPS guidance of 2.150-2.320 for the period, compared to the consensus estimate of 2.160. The company also issued revenue guidance of $235.4 millionillion-$242.8 millionillion, compared to the consensus estimate of $240.2 millionillion.February 28, 2025 | marketbeat.comKeyBanc Reaffirms Their Hold Rating on Lemaitre Vascular (LMAT)February 28, 2025 | markets.businessinsider.comLeMaitre Vascular, Inc. (LMAT) Q4 2024 Earnings Call TranscriptFebruary 28, 2025 | seekingalpha.comLeMaitre sees FY25 EPS $2.15-$2.32, consensus $2.16February 27, 2025 | markets.businessinsider.comLeMaitre (NASDAQ:LMAT) Misses Q4 Sales Targets, Stock Drops 11%February 27, 2025 | msn.comLeMaitre Q4 2024 Financial ResultsFebruary 27, 2025 | globenewswire.comWhat To Expect From LeMaitre’s (LMAT) Q4 EarningsFebruary 26, 2025 | msn.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock Position Lifted by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC grew its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 48.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,321 shares of the meFebruary 23, 2025 | marketbeat.comCompass Planning Associates Inc Acquires Shares of 6,153 LeMaitre Vascular, Inc. (NASDAQ:LMAT)Compass Planning Associates Inc bought a new position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 6,153 shares of the medical instruments supplier's stock,February 22, 2025 | marketbeat.comLeMaitre Vascular (LMAT) to Release Earnings on ThursdayLeMaitre Vascular (NASDAQ:LMAT) will be releasing earnings after the market closes on Thursday, February 27, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=659618)February 20, 2025 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Rice Hall James & Associates LLCRice Hall James & Associates LLC decreased its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 10.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 235,076 shares of the medical instruments supplier's stock after selling 26February 18, 2025 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Purchased by Congress Asset Management Co.Congress Asset Management Co. raised its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 1.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 722,325 shares of the medical instruments supplier's stock aFebruary 16, 2025 | marketbeat.comLake Street Sticks to Their Buy Rating for Lemaitre Vascular (LMAT)February 14, 2025 | markets.businessinsider.comWells Fargo Initiates Coverage of LeMaitre Vascular (LMAT) with Equal-Weight RecommendationFebruary 13, 2025 | msn.comLeMaitre Vascular Hires CFO from LumiraDxFebruary 13, 2025 | marketwatch.comLeMaitre initiated with an Equal Weight at Wells FargoFebruary 13, 2025 | markets.businessinsider.comWells Fargo sets LeMaitre stock at Equal Weight, $95 targetFebruary 13, 2025 | msn.comLeMaitre Vascular Appoints Dorian LeBlanc as CFOFebruary 13, 2025 | tipranks.comLeMaitre Vascular (NASDAQ:LMAT) Now Covered by Wells Fargo & CompanyWells Fargo & Company began coverage on shares of LeMaitre Vascular in a research note on Thursday. They issued an "equal weight" rating and a $95.00 price target on the stock.February 13, 2025 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Recommendation of "Buy" by AnalystsShares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) have received a consensus rating of "Buy" from the eight research firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating, six have assigned a buy rating and oneFebruary 11, 2025 | marketbeat.com Remove Ads Get LeMaitre Vascular News Delivered to You Automatically Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter. Email Address LMAT Media Mentions By Week LMAT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LMAT News Sentiment▼1.430.63▲Average Medical News Sentiment LMAT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LMAT Articles This Week▼54▲LMAT Articles Average Week Remove Ads Get LeMaitre Vascular News Delivered to You Automatically Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies STVN News GKOS News BLCO News INSP News NARI News PRCT News IRTC News NVST News TMDX News SLNO News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LMAT) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LeMaitre Vascular, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LeMaitre Vascular With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LMAT Stock Free LMAT Stock Alerts